Andy Pasternak, EVP and Chief Business Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 9,700 shares at $82.44 ($801K) on 2022-07-29, disclosed to the SEC on 2022-07-29.
Open-market sale of $801k HZNP by EVP and Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.44 | 4,207 | $347K | 43.3% |
| 2 | $82.44 | 4,207 | $347K | 43.3% |
| 3 | $83.45 | 643 | $54K | 6.7% |
| 4 | $83.45 | 643 | $54K | 6.7% |
| Total | $82.57 avg | 9,700 | $801K | 100% |
| Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-02-18 | $249K | — | Filing → |
| HZNP | SELL | 2022-01-06 | $1.4M | — | Filing → |